United Therapeutics Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 210.9 | 159.6 | 115.9 |
| Cost of Goods Sold | 22.3 | 17.0 | 12.3 |
| Gross Profit | 188.7 | 142.6 | 103.6 |
| Gross Profit Margin | 89.4% | 89.3% | 89.4% |
| SG&A Expense | 181.4 | 112.2 | 58.3 |
| Depreciation & Amortization | 1.0 | 1.5 | 2.4 |
| Operating Income | 6.3 | 29.0 | 42.9 |
| Operating Margin | 3.0% | 18.2% | 37.0% |
| Nonoperating Income | 12.8 | 11.9 | 4.7 |
| Nonoperating Expenses | 2.2 | 0.5 | 0.0 |
| Income Before Taxes | 16.6 | 39.9 | 47.5 |
| Income Taxes | (3.3) | (34.1) | (17.5) |
| Net Income After Taxes | 19.9 | 74.0 | 65.0 |
| Continuing Operations | 19.9 | 74.0 | 65.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 19.9 | 74.0 | 65.0 |
| Total Net Income | 19.9 | 74.0 | 65.0 |
| Net Profit Margin | 9.4% | 46.3% | 56.1% |
| Diluted EPS from Total Net Income ($) | 0.88 | 3.06 | 2.58 |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
